Guidelines for the clinical management of familial adenomatous polyposis (FAP)
暂无分享,去创建一个
P. Møller | G. Capellá | S. Tejpar | J. Mecklin | H. Järvinen | S. Bülow | C. Engel | J. Burn | S. Hodgson | S. Hodgson | I. Bernstein | I. Frayling | J. Sampson | F. Nagengast | H. Vasen | S. Aretz | G. Möslein | I. Blanco | J. Wijnen | L. Bertario | C. Colas | R. Phillips | S. Clark | Y. Parc | F. Hes | H. Thomas | W. Friedl | L. Renkonen-Sinisalo | M. P. de Leon | A. Stormorken | F. Hes | Á. Alonso | I. Blanco | M. León | L. Renkonen‐Sinisalo | G. Moslein | Mecklin Jp | T. Myrhøi | Steffen Bülow | Huber Thomas | S. Clark
[1] Christopher Portier,et al. Risk factors for childhood leukaemia. Discussion and summary. , 2008, Radiation protection dosimetry.
[2] P. Propping,et al. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP) , 2007, Human mutation.
[3] E. Bakker,et al. Somatic APC mosaicism: an underestimated cause of polyposis coli , 2007, Gut.
[4] H. Morreau,et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis , 2007, Clinical genetics.
[5] D. Chung,et al. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] J. Gisbert,et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] J. Kleibeuker,et al. Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] P. Møller,et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) , 2007, Journal of Medical Genetics.
[9] S. Skapek,et al. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Nieuwenhuis,et al. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. , 2007, Critical reviews in oncology/hematology.
[11] J. Baron,et al. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. , 2006, Gastroenterology.
[12] P. Propping,et al. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? , 2006, Pediatric blood & cancer.
[13] P. McGettigan,et al. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. , 2006, JAMA.
[14] R. Phillips,et al. A 10‐year review of surgery for desmoid disease associated with familial adenomatous polyposis , 2006, The British journal of surgery.
[15] E. Kuipers,et al. Duodenal carcinoma in MUTYH-associated polyposis , 2006, Journal of Clinical Pathology.
[16] P. Propping,et al. MUTYH‐associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype , 2006, International journal of cancer.
[17] T. Athanasiou,et al. Meta‐analysis of observational studies of ileorectal versus ileal pouch–anal anastomosis for familial adenomatous polyposis , 2006, The British journal of surgery.
[18] E. Kuipers,et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP) , 2005, Journal of Medical Genetics.
[19] J. Prendergast,et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. , 2005, American journal of human genetics.
[20] M. Goggins,et al. Prevention and management of duodenal polyps in familial adenomatous polyposis , 2005, Gut.
[21] A. Tenesa,et al. Re: Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. , 2005, Journal of the National Cancer Institute.
[22] I. Tomlinson,et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation , 2004, Gut.
[23] Eric J Topol,et al. Failing the public health--rofecoxib, Merck, and the FDA. , 2004, The New England journal of medicine.
[24] M. Leppert,et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. , 2004, Gastroenterology.
[25] S. Clark,et al. High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors , 2004, Cancer.
[26] P. Radice,et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas , 2004, International journal of cancer.
[27] W. Bemelman,et al. Adenocarcinoma in the anal canal after heal pouch-anal anastomosis for familial adenomatous polyposis using a double-stapled technique: Report of two cases , 2004, Diseases of the colon and rectum.
[28] I. Christensen,et al. Duodenal adenomatosis in familial adenomatous polyposis , 2004, Gut.
[29] R. Écochard,et al. Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] S. Bülow,et al. Results of national registration of familial adenomatous polyposis , 2003, Gut.
[31] L. Lipton,et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. , 2003, The New England journal of medicine.
[32] S. Laurberg,et al. Female fecundity before and after operation for familial adenomatous polyposis , 2003, The British journal of surgery.
[33] G. Aravantinos,et al. The pharmacological treatment of aggressive fibromatosis: a systematic review. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[34] E. Boh,et al. Cutaneous manifestations of gastrointestinal diseases. , 2002, Dermatologic clinics.
[35] B. Levin,et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis , 2002, Gut.
[36] A. Spigelman,et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study , 2002, Gut.
[37] S. Piantadosi,et al. Primary chemoprevention of familial adenomatous polyposis with sulindac , 2002 .
[38] Alison L. Livingston,et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.
[39] F. Giardiello,et al. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. , 2001, Gastroenterology.
[40] J. Gebert,et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families , 2001, Gut.
[41] P. Radice,et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis , 2001, International journal of cancer.
[42] S. Olschwang,et al. Familial Adenomatous Polyposis: Prevalence of Adenomas in the Ileal Pouch After Restorative Proctocolectomy , 2001, Annals of surgery.
[43] H. Järvinen,et al. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. , 2000, Gastroenterology.
[44] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[45] H. Vasen. When should endoscopic screening in familial adenomatous polyposis be started? , 2000, Gastroenterology.
[46] P. Radice,et al. Genotype and Phenotype Factors as Determinants for Rectal Stump Cancer in Patients With Familial Adenomatous Polyposis , 2000 .
[47] Charles R. Thomas,et al. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors , 2000, Cancer.
[48] H. Järvinen,et al. Management of Duodenal Adenomas in 98 Patients with Familial Adenomatous Polyposis , 1999, Endoscopy.
[49] J. Guillem,et al. Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis , 1999, Journal of Gastrointestinal Surgery.
[50] A. Fusco,et al. Genetic Alterations in Thyroid Carcinoma Associated with Familial Adenomatous Polyposis: Clinical Implications and Suggestions for Early Detection , 1998, World Journal of Surgery.
[51] H. Vasen,et al. Occurrence of thyroid carcinoma in Dutch patients with familial adenomatous polyposis. An epidemiological study and report of new cases , 1998, European journal of gastroenterology & hepatology.
[52] J. Church,et al. Incidence of neoplastic polyps in the ileal pouch of patients with familial adenomatous polyposis after restorative proctocolectomy , 1998, Diseases of the colon and rectum.
[53] S. Bülow,et al. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? , 1997, International Journal of Colorectal Disease.
[54] S. Travis,et al. Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group. , 1997, European journal of gastroenterology & hepatology.
[55] E. Buskens,et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. , 1997, Gut.
[56] A. Botha,et al. Desmoids in familial adenomatous polyposis , 1997, The British journal of surgery.
[57] G. Petersen,et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. , 1996, Gut.
[58] C. Tops,et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis , 1996, The Lancet.
[59] Z. Cohen,et al. Changing causes of mortality in patients with familial adenomatous polyposis , 1996, Diseases of the colon and rectum.
[60] R. Gardner,et al. Familial adenomatous polyposis in a 5 year old child: a clinical, pathological, and molecular genetic study. , 1996, Journal of medical genetics.
[61] S. Bülow,et al. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register. , 1995, Scandinavian journal of gastroenterology.
[62] K. Schmid,et al. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment , 1995, Diseases of the colon and rectum.
[63] G. Thomas,et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. , 1995, Human molecular genetics.
[64] H. Lynch,et al. Rectal cancer after prolonged sulindac chemoprevention. A case report , 1995, Cancer.
[65] C. Rossetti,et al. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. , 1994, Seminars in surgical oncology.
[66] G. Petersen,et al. Desmoid tumours in familial adenomatous polyposis. , 1994, Gut.
[67] A. Spigelman,et al. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis , 1993, Diseases of the colon and rectum.
[68] S. Piantadosi,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.
[69] I. Song,et al. Risk of gastric cancer among Korean familial adenomatous polyposis patients , 1992, Diseases of the colon and rectum.
[70] P. Vielh,et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.
[71] V. Fazio,et al. Mortality in patients with familial adenomatous polyposis , 1990, Diseases of the colon and rectum.
[72] G. Griffioen,et al. The value of screening and central registration of families with familial adenomatous polyposis , 1990, Diseases of the colon and rectum.
[73] A. Spigelman,et al. UPPER GASTROINTESTINAL CANCER IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS , 1989, The Lancet.
[74] Steffen Bülow. Clinical features in familial polyposis coli , 1986, Diseases of the colon and rectum.
[75] R. Coffey,et al. Gastric adenocarcinoma complicating Gardner's syndrome in a North American woman. , 1985, Gastroenterology.
[76] H. Järvinen,et al. Finnish registry for familial adenomatosis coli. , 1984, Scandinavian journal of gastroenterology.
[77] W. Waddell,et al. Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.
[78] J. Jorizzo,et al. Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. , 1983, Archives of internal medicine.
[79] F. Greenway,et al. Cutaneous lesions after intestinal bypass. , 1980, Annals of internal medicine.
[80] H. Bussey. Familial polyposis coli. , 1975, Pathology annual.
[81] E. Loizeau. [Crohn's disease or ulcerative colitis?]. , 1969, Praxis.
[82] J. J. Buckley,et al. Report of Three Cases , 1962 .
[83] H. Ikeuchi,et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] I. Blanco,et al. [Familial adenomatous polyposis]. , 2006, Gastroenterologia y hepatologia.
[85] S. Clark,et al. Current ideas in desmoid tumours , 2005, Familial Cancer.
[86] C. Sempoux,et al. Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited , 2005, Familial Cancer.
[87] S. Bülow,et al. Desmoid tumour in familial adenomatous polyposis. A review of literature , 2004, Familial Cancer.
[88] P. Propping,et al. Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis , 2004, European Journal of Human Genetics.
[89] J. Knight,et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. , 2004, Journal of the National Cancer Institute.
[90] S. Bülow,et al. Attenuated familial adenomatous polyposis (AFAP): a review of the literature , 2004, Familial Cancer.
[91] A. Russo,et al. Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry. , 2000, Annals of surgery.
[92] H. Järvinen,et al. Impact of screening examinations on survival in familial adenomatous polyposis. , 2000, Scandinavian journal of gastroenterology.
[93] H. Kogelnik. [Surgery versus radiotherapy for patients with aggressive fibromatosis or desmoid tumors. A comparative review of 22 articles]. , 2000, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[94] J. Church,et al. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. , 1998, Annals of surgery.
[95] H. Järvinen,et al. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment , 1996, International Journal of Colorectal Disease.
[96] M. Bisgaard,et al. Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate , 1994, Human mutation.
[97] D. S. Santa Cruz,et al. Neutrophilic dermatoses. , 1989, Seminars in dermatology.
[98] T. Alm. Surgical treatment of hereditary adenomatosis of the colon and rectum in Sweden during the last 20 years. Part II. Patients with prophylactic operations, primary and late results. Discussion and summary. , 1975, Acta chirurgica Scandinavica.